Biotech · Private company
Amzell
Track this companyFree. Adds Amzell to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AMZ001Phase 3 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- AMZ001 Diclofenac gelPhase 3 · Osteoarthritis of KneeClinicalTrials.gov · fetched Nov 12, 2026
- AMZ002 injectable solution, 0.5mg/mLPhase 3 · Spasms, InfantileClinicalTrials.gov · fetched Nov 12, 2026
- ComparatorPhase 3 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- Vigabatrin, oralPhase 3 · Spasms, InfantileClinicalTrials.gov · fetched Nov 12, 2026
- Diclofenac Sodium GelPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis SymptomsPHASE3 · COMPLETED · started Feb 18, 2025ClinicalTrials.gov NCT06693648 · fetched Nov 12, 2026
- Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy ParticipantsPHASE1 · COMPLETED · started Jul 11, 2023ClinicalTrials.gov NCT05968482 · fetched Nov 12, 2026
- A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile SpasmsPHASE3 · WITHDRAWN · started Apr 1, 2023ClinicalTrials.gov NCT05128344 · fetched Nov 12, 2026
- AMZ001 for the Treatment of Knee Osteoarthritis SymptomsPHASE2_PHASE3 · COMPLETED · started Oct 4, 2018ClinicalTrials.gov NCT03691844 · fetched Nov 12, 2026